The platelet count was markedly decreased after ConA treatment (P < 0.01) (Fig. 2c), which was concomitant with significantly increased serum ALT and AST levels, resembling hypersplenism with cirrhosis in humans. This evidence concerns the gene GPT and hypersplenism.